A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects
Clinical trial NCT02436928 · COMPLETED
Trial details
- NCT number
- NCT02436928
- Sponsor
- Medigen Vaccine Biologics Corp.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-02-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.